LOQTORZI DIN 02562219
Health Canada record
| Active ingredient(s) | TORIPALIMAB 40 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION; SCHEDULE D |
| Class | Human |
| ATC | L01FF13 TORIPALIMAB |
| Original market date | 26-Jan-2026 |
| Current status date | 26-Jan-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36209 | 2025-10-17 | New Drug Submission (NDS) |